iGenomeDx Bringing Personalized Medicine to San Antonio, TX

SAN ANTONIO - Nov. 9, 2016 - PRLog -- Dr. Pramod Kumar Mishra Ph.D. in Microbiology and Immunology along with Dr. Niti Vanee, Ph.D. in Bioinformatics and Systems Biology have formed iGenomeDx, Inc., a new Pharmacogenomics laboratory in San Antonio, TX.

Pharmacogenomics is the study of how genes affect a person's response to drugs. This field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to qualify a safe medication and dosage tailored to a person's genetic DNA. This one-time, simple swab test has become the most accurate method of determining appropriate drug compounds and correct dosages. The results can reduce polypharmacy (the simultaneous use of multiple drugs to treat a single ailment or condition) and an overall reduction to the cost of health care by decreasing the number of adverse drug reactions, the length of time a patient relies on medication, the number of medications patients must take to find an effective therapy, the effects of a disease on the body through early detection, and the number of failed drug trials. Patients can now get the right medication the first time and every time.

If your physician isn't using this proven, insurance-approved, low-cost practice, he/she will be very soon.

The iGenomeDx laboratory is scheduled to open in San Antonio, and is looking for qualified investors at this time. The investment is in preferred shares and a promissory note paying 12% annually over two years.

This is not an offer to sell or a solicitation of any offer to buy any securities. Offers are made only by prospects or other offering materials. To obtain further information, you must complete our investor questionnaire & meet suitability standards required by law.

For more information, go to https://www.igdxppm.com or call Rudy De la Garza at (866) 511-4623.